Effects of Probiotics on diarrhea

Not Applicable

• Conditions: eoplasms.; Malignant neoplasm of small intestine, Malignant neoplasm of colon, Malignant neoplasm of rectosigmoid junction, Malignant neoplasm of rectum; C17, C18,

• Registration Number: IRCT2015030421338N1
• Lead Sponsor: Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

The inclusion criteria: Patients with pelvic cancers (colorectal, prostate, endometrial, bladder, ovary, cervical, bone sarcoma) who undergo pelvic radiotherapy.
The exclusion criteria: The presence of any acute or chronic gastrointestinal condition associated with diarrhea before recruitment and getting pelvic radiotherapy in the past.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diarrhea grade. Timepoint: Weekly from one week before radiotherapy until end of treatment. Method of measurement: Common Toxicity Criteria system.;Stool consistency score. Timepoint: Weekly from one week before radiotherapy until end of treatment. Method of measurement: Bristol scales.;Blood cell counts. Timepoint: Weekly from one week before radiotherapy until end of treatment. Method of measurement: cell counter machine.;Serum IgA level. Timepoint: Weekly from one week before radiotherapy until end of treatment. Method of measurement: Autoanalyzer machine.

Secondary Outcome Measures

Name	Time	Method
Bloting. Timepoint: Weekly during treatment. Method of measurement: Question from the patient.